These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum beta-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria. Stürenburg E; Lang M; Horstkotte MA; Laufs R; Mack D J Antimicrob Chemother; 2004 Nov; 54(5):870-5. PubMed ID: 15471997 [TBL] [Abstract][Full Text] [Related]
44. Leg ulcer and bacteremia due to Cedecea davisae. Dalamaga M; Pantelaki M; Karmaniolas K; Matekovits A; Daskalopoulou K Eur J Dermatol; 2008; 18(2):204-5. PubMed ID: 18424396 [No Abstract] [Full Text] [Related]
45. Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals. Falagas ME; Skalidis T; Vardakas KZ; Legakis NJ; J Antimicrob Chemother; 2017 Jun; 72(6):1704-1708. PubMed ID: 28369471 [TBL] [Abstract][Full Text] [Related]
46. Comparative evaluation of the Vitek-2 Compact and Phoenix systems for rapid identification and antibiotic susceptibility testing directly from blood cultures of Gram-negative and Gram-positive isolates. Gherardi G; Angeletti S; Panitti M; Pompilio A; Di Bonaventura G; Crea F; Avola A; Fico L; Palazzo C; Sapia GF; Visaggio D; Dicuonzo G Diagn Microbiol Infect Dis; 2012 Jan; 72(1):20-31. PubMed ID: 22030102 [TBL] [Abstract][Full Text] [Related]
47. Emergence of armA and rmtB genes among VIM, NDM, and IMP metallo-β-lactamase-producing multidrug-resistant Gram-negative pathogens. Gopalakrishnan S; Kamalanathan A; Rajan S; Bhagat VM; Ali MKS Acta Microbiol Immunol Hung; 2018 Mar; 65(1):107-118. PubMed ID: 28870092 [TBL] [Abstract][Full Text] [Related]
48. Clinical and microbiological implications of time-to-positivity of blood cultures in patients with Gram-negative bacilli bacteremia. Palmer HR; Palavecino EL; Johnson JW; Ohl CA; Williamson JC Eur J Clin Microbiol Infect Dis; 2013 Jul; 32(7):955-9. PubMed ID: 23397233 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of the KPC K-SeT® immunochromatographic assay for the rapid detection of KPC carbapenemase producers from positive blood cultures. Riccobono E; Antonelli A; Pecile P; Bogaerts P; D'Andrea MM; Rossolini GM J Antimicrob Chemother; 2018 Feb; 73(2):539-540. PubMed ID: 29126269 [No Abstract] [Full Text] [Related]
50. Evaluation of a new Rapid Antimicrobial Susceptibility system for Gram-negative and Gram-positive bloodstream infections: speed and accuracy of Alfred 60AST. Anton-Vazquez V; Adjepong S; Suarez C; Planche T BMC Microbiol; 2019 Nov; 19(1):268. PubMed ID: 31783787 [TBL] [Abstract][Full Text] [Related]
51. Strategy for rapid identification and antibiotic susceptibility testing of gram-negative bacteria directly recovered from positive blood cultures using the Bruker MALDI Biotyper and the BD Phoenix system. Wimmer JL; Long SW; Cernoch P; Land GA; Davis JR; Musser JM; Olsen RJ J Clin Microbiol; 2012 Jul; 50(7):2452-4. PubMed ID: 22518850 [TBL] [Abstract][Full Text] [Related]
52. Rapid molecular tests for detection of antimicrobial resistance determinants in Gram-negative organisms from positive blood cultures: a systematic review and meta-analysis. De Angelis G; Grossi A; Menchinelli G; Boccia S; Sanguinetti M; Posteraro B Clin Microbiol Infect; 2020 Mar; 26(3):271-280. PubMed ID: 31751768 [TBL] [Abstract][Full Text] [Related]
53. Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli. Zhanel GG; Chung P; Adam H; Zelenitsky S; Denisuik A; Schweizer F; Lagacé-Wiens PR; Rubinstein E; Gin AS; Walkty A; Hoban DJ; Lynch JP; Karlowsky JA Drugs; 2014 Jan; 74(1):31-51. PubMed ID: 24352909 [TBL] [Abstract][Full Text] [Related]